Group items tagged

[No of pages - 280 ] Browse 120 market tables and 29 figures/charts on North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

[Price: $4650] [No of pages - 280 ] Browse 120 market tables and 29 figures/charts on North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

[271 Pages Report] North American Home Healthcare Market report categorizes the global health care market by Services (Respiratory Therapy, Rehabilitation Therapy)by product (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit) & by Geography

North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017

North American Healthcare IT Market, By Application [Provider IT (EMR, PACS, CPOE, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component -Forecasts to 2017

North American Drug Delivery Technology Market categories the global market by technology (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) & by Geography

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

The North America home healthcare market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017.

North America Injectables Drug Delivery Market- by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017

North America dominated the market, with the U.S. accounting for a major market share. Asia is poised to grow at the highest CAGR during the forecast period. The large share of the North American market can be attributed to factors such as rising incidences of chronic diseases, expanding biotechnology and pharmaceutical industries, government support, and the launch of new products in the region.

Discover how to reduce health care disparities for vulnerable populations, including racial and ethnic minorities.

Check out the new issue of the Innovations Exchange which features programs that developed improvements in the management of cardiovascular disease and chronic conditions.

The program has enhanced access to acupuncture and herbal treatments for low-income individuals with HIV/AIDS and other chronic illnesses, reduced side effects from antiretroviral therapy, and alleviated pain in patients experiencing chronic pain.